Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» JNJ
JNJ
J&J Extends Lifeline to Nanobiotix in Potential $1.8B Licensing Deal
BioSpace
Mon, 07/10/23 - 09:36 pm
JNJ
Nanobiotix
NBTXR3
radiotherapy
head and neck cancer
Janssen’s trial of plaque psoriasis therapy meets endpoints
Clinical Trials Arena
Wed, 07/5/23 - 10:18 am
Janssen
JNJ
clinical trials
JNJ-2113
plaque psoriasis
Former J&J sales rep indicted on charges of defrauding Boston hospital
Medtech Dive
Thu, 06/29/23 - 11:37 am
Medtech
fraud
JNJ
DePuy Synthes
legal
Boston
10 clinical trials to watch in the second half of 2023
BioPharma Dive
Wed, 06/28/23 - 11:44 am
FDA
clinical trials
Sarepta Therapeutics
Bridge Bio
Sanofi
Merck KGaA
Pfizer
Novo Nordisk
Verve Therapeutics
Roche
Vertex Pharmaceuticals
JNJ
Bristol Myers Squibb
ATTR-CM
Elevidys
tolebrutinib
evobrutinib
danuglipron
tiragolumab
VX-548
lazertinib
‘You not only know us, you love and trust us:’ How J&J spinoff Kenvue is raising its profile
Medical Marketing and Media
Mon, 06/26/23 - 08:37 pm
JNJ
spinoffs
Kenvue
consumer health
GE HealthCare partners with J&J to push spine imaging system
Medtech Dive
Thu, 06/22/23 - 11:31 am
Medtech
GE Healthcare
JNJ
DePuy Synthes
spine imaging
OEC 3D Imaging System
J&J, Deloitte launch Illustrate Change, a library of diverse medical images
Medical Marketing and Media
Tue, 06/20/23 - 09:52 pm
JNJ
Deloitte
medical images
Abbott’s $1.9B electrophysiology unit threatened by pulsed field ablation: analysts
Medtech Dive
Tue, 06/13/23 - 10:54 pm
Medtech
Abbott Labs
pulsed field ablation
JNJ
Medtronic
Boston Scientific
EHA 2023: Janssen’s talquetamab shows promise in multiple myeloma
Clinical Trials Arena
Tue, 06/13/23 - 10:39 am
talquetamab
JNJ
Multiple Myeloma
Johnson & Johnson inks another Stelara patent settlement, this time with Alvotech and Teva
Fierce Pharma
Mon, 06/12/23 - 11:36 pm
JNJ
Stelara
biosimilars
legal
patents
Teva Pharmaceutical
Alvotech
Pharma Companies, Pharmacies Agree to Pay $19B in Opioid Settlement
BioSpace
Mon, 06/12/23 - 10:15 am
opioids
opioid crisis
legal
pharmacies
McKesson
AmerisourceBergen
Cardinal Health
Teva Pharmaceutical
AbbVie
JNJ
Alkermes, after arbitration win over J&J, jacks up revenue forecast by $425M
Fierce Pharma
Wed, 06/7/23 - 10:18 am
Alkermes
JNJ
nanocrystals
Abiomed heart pump recall labeled Class I by FDA, no deaths reported
Medtech Dive
Tue, 06/6/23 - 09:55 am
JNJ
Abiomed
devices
Medtech
Impella 5.5
product recalls
device recalls
ASCO: Johnson & Johnson's Balversa tops chemotherapy in bladder cancer trial
Fierce Pharma
Mon, 06/5/23 - 10:02 pm
ASCO 2023
JNJ
Balversa
bladder cancer
J&J sees trial data supporting earlier CAR-T use in multiple myeloma
BioPharma Dive
Mon, 06/5/23 - 10:12 am
ASCO 2023
JNJ
Legend Biotech
Carvykti
CAR-T
Multiple Myeloma
AstraZeneca drops Skyrizi rival after seeing R&D timeline spiral
Fierce Biotech
Thu, 06/1/23 - 11:41 am
AstraZeneca
IBD
AbbVie
JNJ
brazikumab
Skyrizi
Stelara
Johnson & Johnson cites rebates and discounts for drug price increases
Fierce Pharma
Mon, 05/29/23 - 12:09 pm
JNJ
drug pricing
drug rebates
drug discounts
Johnson & Johnson’s Tremfya outshines IL-17 inhibitors as plaque psoriasis treatment
Clinical Trials Arena
Thu, 05/25/23 - 12:48 pm
JNJ
Janssen
Tremfya
psoriasis
real world data
Amgen settles patent lawsuit over biosimilar of J&J's big-selling Stelara
Yahoo/Reuters
Tue, 05/23/23 - 06:14 pm
JNJ
Amgen
patents
Stelara
biosimilars
legal
J&J beats back Viatris' generic challenge to schizophrenia med Invega Trinza
Fierce Pharma
Thu, 05/18/23 - 11:16 am
JNJ
schizophrenia
generics
Trinza
Viatris
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
…
next ›
last »